apl. Prof. Dr. Alexander Hein



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer (2016) Hollestelle A, Van Der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomaki K, et al. Journal article Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer (2016) French JD, Johnatty SE, Lu Y, Beesley J, Gao B, Kalimutho M, Henderson MJ, et al. Journal article Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer (2016) Painter JN, O'Mara TA, Marquart L, Webb PM, Attia J, Medland SE, Cheng T, et al. Journal article Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients (2016) Hein A, Gaß P, Walter CB, Taran FA, Hartkopf A, Overkamp F, Kolberg HC, et al. Journal article Five endometrial cancer risk loci identified through genome-wide association analysis (2016) Cheng THT, Thompson DJ, O'Mara TA, Painter JN, Glubb DM, Flach S, Lewis A, et al. Journal article CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer (2016) Thompson DJ, O'Mara TA, Glubb DM, Painter JN, Cheng T, Folkerd E, Doody D, et al. Journal article Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer (2016) Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Doerk T, Hillemanns P, et al. Journal article PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS (2016) Southey MC, Goldgar DE, Winqvist R, Pylkas K, Couch F, Tischkowitz M, Foulkes WD, et al. Journal article (Neo-)Adjuvant and first-line therapy: Prognostic and predictive factors (Neo-)Adjuvanten und First-Line-Therapie: Prognostische und prädiktive Faktoren (2015) Lux MP, Oenuegoeren O, Wunderle M, Hein A, Rauh C, Schrauder MG, Fasching P, Beckmann M Journal article Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci (2015) Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, Rhie SK, et al. Journal article